Orencia Alternatives Compared
Orencia | Otezla | Tremfya |
|
---|
Orencia (abatacept) | Otezla (apremilast) | Tremfya (guselkumab) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Orencia is a selective immunosuppressant that may be used to treat inflammatory conditions such as rheumatoid arthritis or psoriatic arthritis. It is administered by intravenous infusion every 4... View more |
Prescription only
Otezla is a PDE4 inhibitor that may be used to treat adults with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s Disease. It may also be used to treat plaque psoriasis... View more |
Prescription only
Tremfya is an interleukin inhibitor that may be used to treat plaque psoriasis or psoriatic arthritis in adults. People receiving Tremfya can be taught how to self-administer it every eight weeks by... View more |
Related suggestions Popular comparisons
|
|||||||||||||||||||||||
More about Orencia (abatacept) | More about Otezla (apremilast) | More about Tremfya (guselkumab) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Orencia has an average rating of 6.0 out of 10 from a total of 70 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 35% reported a negative effect. |
Otezla has an average rating of 5.2 out of 10 from a total of 438 ratings on Drugs.com. 34% of reviewers reported a positive effect, while 41% reported a negative effect. |
Tremfya has an average rating of 7.0 out of 10 from a total of 86 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Orencia side effects in more detail. |
See also: Otezla side effects in more detail. |
See also: Tremfya side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Orencia prices |
View all Otezla prices |
View all Tremfya prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
600 hours |
9 hours |
432 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 159 drugs are known to interact with Orencia:
|
A total of 88 drugs are known to interact with Otezla:
|
A total of 229 drugs are known to interact with Tremfya:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
December 23, 2005 |
March 21, 2014 |
July 13, 2017 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.